Monday, 6 February 2023

Business News

Pliant Therapeutics 8.33M share Secondary priced at $30.00

Unity Biotechnology reports Q3 EPS ($1.36), consensus ($1.65)

Previous Post

Analysts Conflicted on These Materials Names: AIC Mines Limited (OtherIAUFF) and Sandfire Resources Limited (OtherSFRRF)

Next Post

Pliant Therapeutics Announces Pricing of Upsized $250.0 Million Public Offering

Click Here to Read the Full Original Article at TipRanks Financial Blog…